**Core Concept**
Clear cell renal cell carcinoma (ccRCC) is a common subtype of kidney cancer characterized by the presence of clear cells in the tumor. It is associated with genetic mutations that affect the regulation of cellular metabolism and response to hypoxia.

**Why the Correct Answer is Right**
The clear cell variety of renal cell carcinoma is primarily related to mutations in the VHL gene, which is located on chromosome 3p25-26. The VHL gene acts as a tumor suppressor, regulating the degradation of hypoxia-inducible factors (HIFs) under normal conditions. Mutations in VHL lead to the accumulation of HIF, resulting in the upregulation of genes involved in angiogenesis, cell proliferation, and glucose metabolism, ultimately contributing to tumor development. The VHL gene is a key player in the regulation of cellular response to hypoxia, and its inactivation is a hallmark of clear cell RCC.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect as it does not specify a particular chromosome or gene associated with clear cell RCC.
* **Option B:** This option is incorrect as it is related to another type of cancer, specifically a gene associated with retinoblastoma, not clear cell RCC.
* **Option C:** This option is incorrect as it is associated with a different type of renal cell carcinoma, specifically papillary RCC, not clear cell RCC.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that clear cell RCC is often associated with a mutation in the VHL gene, which leads to the accumulation of HIF and subsequent upregulation of genes involved in tumor development. This knowledge can help in identifying high-risk patients and developing targeted therapies.

**Correct Answer:** C. 3p25-26